| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...

With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are communicating increasing concern about potential product development ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...